The bright side of covid
COVID-19 triggered a surge in interest in artificial intelligence for healthcare, bringing urgency to longstanding challenges. The trend promises to pick up significant pace over the coming years.
Examples of what we can expect in the coming years include AI tools that personalise treatment based on genetic data, systems that help detect early-stage diseases with unprecedented accuracy, and tools that simplify administrative tasks to free up clinicians’ time.
During the pandemic, AI became essential for tracking outbreaks, forecasting patient needs, and even identifying treatment options. It proved AI's power to manage complex data and support rapid, accurate decisions in critical situations, setting a new standard for AI’s potential in healthcare.
In the next few years, we can expect to see AI's role in healthcare expand rapidly. Hospitals and clinics are increasingly adopting AI-powered tools to improve diagnostics, streamline workflows, and ease clinician workloads.
Experts from organisations like the World Health Organization (WHO), the American Medical Association (AMA), and technology leaders such as GE HealthCare and IBM Watson Health anticipate that by 2030, AI will become integral to routine healthcare.
Over the past decade, AI has had some noteworthy breakthroughs, such as:
However, several factors could impede these developments. Concerns around data privacy and security remain a significant barrier, as handling sensitive patient data requires stringent protections.
Data confidentiality remains an unresolved issue
Additionally, healthcare’s limited infrastructure in some regions may delay AI’s wider adoption, especially where technical training and funding are lacking. Finally, regulatory hurdles and the need for transparent, explainable AI models are critical issues that must be addressed to ensure AI can be safely and fairly integrated into healthcare practices worldwide.
Short-term news cycles are always pessimistic. Zoom out. #TheBrightSide